The DTC Insider · 2026-04-24 · 43 min
In this episode of The DTC Insider, Brian Roisentul sits down with Lekha Vyas, founder of SynQ Wellness , to talk about one of the most talked about trends in health right now: GLP-1 and what comes next. From her background leading brands at companies like L’Oréal and Estée Lauder to building a new category in wellness, Lekha shares how she’s developing a plant-based alternative to GLP-1 drugs, delivered through a Listerine style strip that dissolves in your mouth. They dive into the real impact of GLP-1 drugs, including long term side effects, dependency, and why more consumers are starting to question them. Lekha also explains the science behind sublingual delivery, how it bypasses the gut, and why it could change the future of supplements and metabolic health. Plus, she breaks down what it actually takes to build a breakthrough product, from 75+ formula iterations to early human testing, and how she’s approaching go to market, TikTok, and DTC in a hyper competitive landscape. - This episode is
The Profit-First Approach to E-Commerce Growth72 / 100
Form shopify startup to Walmart shelves: building a category leader.
Why most brands don't connect with their customers (and how to fix it)
Avoid These 5 Costly Mistakes in Q2 Scaling
The Most Overlooked Growth Lever in E-commerce (And It’s Not Your Ads)